参考文献/References:
[1] 王辰,王建安,黄从新,等. 内科学[M]. 第3版.北京:人民卫生出版社,2015:234.
[2] Codvelle MM,Boucher H. Tachycardie sinusale permanente a haute frequence sans troubles functionells[J]. Bull Mem Soc Med Hop Paris,1939,54:1849-1852.
[3] Wising P. Familial,congenital sinus tachycardia[J]. Am Heart J,1942,24(2):279.
[4] Bauernfeind?RA,Amat-Y-Leon?F,Dhingra?RC,et al. Chronic nonparoxysmal sinus tachycardia in otherwise healthy persons[J]. Ann Intern Med,1979,91(5):702-710.
[5] Shabtaie SA,Witt CM,Asirvatham SJ. Natural history and clinical outcomes of inappropriate sinus tachycardia[J]. J Cardiovasc Electrophysiol,2020,31(1):137-143.
[6] Lerebours G. Sinus rhythm:mechanisms and function[J]. Med Sci(Paris),2007,23(6-7):657-662.
[7] Morillo CA,Klein GJ,Thakur RK,et al. Mechanism of“inappropriate”sinus tachycardia.Role of sympathovagal balance[J]. Circulation,1994,90(2):873-877.
[8] Field ME,Donateo P,Bottoni N,et al. P-Wave amplitude and PR changes in patients with inappropriate sinus tachycardia:findings supportive of a central mechanism[J]. J Am Heart Assoc,2018,7(9):e008528.
[9] Nwazue VC,Paranjape SY,Black BK,et al. Postural tachycardia syndrome and inappropriate sinus tachycardia:role of autonomic modulation and sinus node automaticity[J]. J Am Heart Assoc,2014,3(2):e000700.
[10] Castellanos A,Moleiro F,Chakko S,et al. Heart rate variability in inappropriate sinus tachycardia[J]. Am J Cardiol ,1998,82(4):531-534.
[11] Chiale PA,Garro HA,Schmidberg J,et al. Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac β andrenergic receptors[J]. Heart Rhythm,2006,3(10):1182-1186.
[12] Baruscotti M,Bianco E,Bucchi A,et al. Current understanding of the pathophysiological mechanisms responsible for inappropriate sinus tachycardia:role of the If “funny” current[J]. J Interv Card Electrophysiol ,2016,46(1):19-28.
[13] Sheldon RS,Grubb BP 2nd,Olshansky B,et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome,inappropriate sinus tachycardia,and vasovagal syncope[J]. Heart Rhythm,2015,12(6):e41-e63.
[14] Still AM,Raatikainen P,Ylitalo A,et al. Prevalence,characteristics and natural course of inappropriate sinus tachycardia[J]. Europace,2005,7(2):104-112.
[15] Olshansky B,Sullivan RM. Inappropriate sinus tachycardia[J]. Europace,2019,21(2):194-207.
[16] Katritsis DG,Boriani G,Cosio FG,et al. European Heart Rhythm Association(EHRA) consensus document on the management of supraventricular arrhythmias,endorsed by Heart Rhythm Society(HRS),Asia-Pacific Heart Rhythm Society(APHRS),and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia(SOLAECE)[J]. Europace,2017,19(3):465-511.
[17] Martino A,Rebecchi M,Sette A,et al. Ivabradine versus bisoprolol in the treatment of inappropriate sinus tachycardia[J]. J Cardiovasc Med (Hagerstown),2021,22(11):892-900.
[18] Ptaszynski P,Kaczmarek K,Ruta J,et al. Metoprolol succinate vs.ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy[J]. Europace,2013,15(1):116-121.
[19] Ptaszynski P,Kaczmarek K,Ruta J,et al. Ivabradine in the treatment of inappropriate sinus tachycardia in patients after successful radiofrequency catheter ablation of atrioventricular node slow pathway[J]. Pacing Clin Electrophysiol ,2013,36(1):42-49.
[20] Gianni C,di Biase L,Mohanty S,et al. Catheter ablation of inappropriate sinus tachycardia[J]. J Interv Card Electrophysiol ,2015,46(1):63-69.
[21] Sánchez-Quintana?D,Cabrera?JA,Farré?J,et al. Sinus node revisited in the era of electroanatomical mapping and catheter ablation[J]. Heart,2005,91(2):189-194.
[22] Daher G,Rachwan RJ,Hassanieh I,et al. Long-term outcomes of sinus node modification in patients with severely symptomatic drug-refractory inappropriate sinus tachycardia:a single-center experience[J]. J Interv Card Electrophysiol ,2021,61(3):511-516.
[23] Shabtaie SA,Witt CM,Asirvatham SJ. Efficacy of medical and ablation therapy for inappropriate sinus tachycardia:a single-center experience[J]. J Cardiovasc Electrophysiol ,2021,32(4):1053-1061.
[24] Rodríguez-Ma?ero M,Kreidieh B,Al Rifai M,et al. Ablation of inappropriate sinus tachycardia:a systematic review of the literature[J]. JACC Clin Electrophysiol,2017,3(3):253-265.
[25] Ibarra-Cortez SH,Rodríguez-Ma?ero M,Kreidieh B,et al. Strategies for phrenic nerve preservation during ablation of inappropriate sinus tachycardia[J]. Heart Rhythm,2016,13(6):1238-1245.
[26] Page RL,Joglar JA,Caldwell MA,et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia:a report of the American college of cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society[J]. J Am Coll Cardiol,2016,67(13):e27-e115.
[27] Khiabani AJ,Greenberg JW,Hansalia VH,et al. Late outcomes of surgical ablation for inappropriate sinus tachycardia[J]. Ann Thorac Surg ,2019,108(4):1162-1168.
[28] de Asmundis C,Chierchia GB,Lakkireddy D,et al. Sinus node sparing novel hybrid approach for treatment of inappropriate sinus tachycardia/postural sinus tachycardia:multicenter experience[J]. J Interv Card Electrophysiol,2021 Aug 23. DOI:10.1007/s10840-021-01044-5.
[29] Aalaei-Andabili SH,Miles WM,Burkart TA,et al. Minimally invasive thoracoscopic surgery is an effective approach for treating inappropriate sinus tachycardia[J]. J Cardiovasc Electrophysiol ,2019,30(8):1297-1303.
[30] Lakkireddy D,Garg J,DeAsmundis C,et al. Sinus node sparing hybrid thoracoscopic ablation outcomes in patients with Inappropriate Sinus Tachycardia(SUSRUTA-IST) registry[J]. Heart Rhythm,2021?Jul 30;S1547-5271(21)01877-4. DOI: 10.1016/j.hrthm.2021.07.010.Online ahead of print.
[31] Zhou X,Zhou L,Wang S,et al. The use of noninvasive vagal nerve stimulation to inhibit sympathetically induced sinus node acceleration:a potential therapeutic approach for inappropriate sinus tachycardia[J]. J Cardiovasc Electrophysiol ,2016,27(2):217-223.
[32] Cha YM,Li X,Yang M,et al. Stellate ganglion block and cardiac sympathetic denervation in patients with inappropriate sinus tachycardia[J]. J Cardiovasc Electrophysiol ,2019,30(12):2920-2928.
[33] Weber HP,Heinze A,Ruprecht L,et al. Laser catheter modulation of the sinus node in the treatment of inappropriate sinus tachycardia:experimental and clinical results[J]. J Innov Card Rhythm Manag ,2018,9(7):3232-3238.
相似文献/References:
[1]唐欣 罗素新.心房颤动合并 射血分数保留的心力衰竭的研究进展[J].心血管病学进展,2019,(5):753.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.022]
TANG Xin,LUO Suxin.Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2019,(3):753.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.022]
[2]黄巧娟 周晓莉.冠状动脉慢血流现象的研究进展[J].心血管病学进展,2020,(2):163.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.016]
HUANG QiaojuanZHOU Xiaoli.Coronary Slow Flow Phenomenon[J].Advances in Cardiovascular Diseases,2020,(3):163.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.016]
[3]朱珊英,朱国斌.肺动脉高压发病机制新进展[J].心血管病学进展,2020,(3):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
ZHU Shanying,ZHU Guobin.Pathogenesis of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(3):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
[4]郭辅定 殷铭 赖燕秋 江洪.蒽环类药物相关心血管疾病与自主神经调控展望[J].心血管病学进展,2021,(3):248.[doi:10.16806/j.cnki.issn.1004-3934.20 21.03.014]
GUO Fuding,YIN Ming,LAI Yanqiu,et al.Anthracycline-induced Cardiovascular Diseases and Autonomic Nervous Regulation[J].Advances in Cardiovascular Diseases,2021,(3):248.[doi:10.16806/j.cnki.issn.1004-3934.20 21.03.014]
[5]韩雅洁 范小倩 巩彩霞 赵子龙 乔成栋.致心律失常性左室心肌病的研究进展[J].心血管病学进展,2021,(4):342.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.013]
HAN Yajie,FAN Xiaoqian,GONG Caixia,et al.Arrhythmogenic Left Ventricular Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(3):342.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.013]
[6]聂琼 吴镜.射血分数保留性心力衰竭：从机制到治疗[J].心血管病学进展,2022,(3):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
NIE Qiong,WU Jing.Heart Failure with Preserved Ejection Fraction:from Mechanism to Treatment[J].Advances in Cardiovascular Diseases,2022,(3):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
[7]智慧 赵青 柳志红.慢性血栓栓塞性肺动脉高压发病机制新进展：从基础到临床[J].心血管病学进展,2022,(4):297.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.003]
HUANG Zhihua,LUO Qin,ZHAO Zhihui,et al.Pathogenesis of Chronic Thromboembolic Pulmonary Hypertension:from Bench to Bedside[J].Advances in Cardiovascular Diseases,2022,(3):297.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.003]
[8]丁晓彤 郭俊 王大震 朱胜松 杨斐然 唐闽.肾积水与高血压的研究进展[J].心血管病学进展,2023,(3):212.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.005]
DING Xiaotong,GUO Jun,WANG Dazhen,et al.Hydronephrosis and Hypertension[J].Advances in Cardiovascular Diseases,2023,(3):212.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.005]
[9]张丹 钟广伟 杨海燕 时拥月 秦钦 姚佳梅.左心室心肌致密化不全心肌病的研究进展[J].心血管病学进展,2023,(4):316.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
ZHANG DanZHONG Guangwei,YANG Haiyan,SHI Yongyue,et al.Left Ventricular Noncompaction Cardiomyopathy[J].Advances in Cardiovascular Diseases,2023,(3):316.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
[10]雷悦云 邵磊 高传玉 张优.早发冠心病发病机制相关基因多态性研究进展[J].心血管病学进展,2023,(4):331.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.010]
LEI Yueyun,SHAO Lei,GAO Chuanyu,et al.Gene Polymorphisms related to the Pathogenesis of?remature Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2023,(3):331.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.010]